Cargando...
Novel case of androgen receptor‐positive cancer of unknown primary without serum prostate‐specific antigen elevation that became progression free in the long term after primary combined androgen blockade
INTRODUCTION: The prognosis of cancer of unknown primary is very poor. Such a prognosis can be improved by characterizing primary characteristics and developing tailored site‐specific therapy, especially for androgen receptor‐positive adenocarcinoma. However, in such cases without elevated prostate‐...
Gardado en:
| Publicado en: | IJU Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784734/ https://ncbi.nlm.nih.gov/pubmed/33426501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12241 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|